| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
JBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 386.1K | - | - | |
| CEO | 86.3K | - | - | |
| Dir | 47.7K | - | - | |
| CFO | 37.8K | - | - | |
| Dir | 34.8K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Noyes Timothy P81 | Chief Executive Officer | Sale+OE | 15,000 | $19.39 | $290,916.21 | -100% | -5.4% | +51.7% | |
| Mar 6, 2023 | Dake Benjamin T77 | See Remarks | Sale+OE | 10,282 | $23.73 | $243,953.56 | -100% | -33.3% | -4.4% | |
| Mar 6, 2023 | Niven Ralph74 | Chief Scientific Officer | Sale+OE | 2,250 | $23.75 | $53,439.62 | -58.3% | -33.3% | -4.4% | |
| Mar 1, 2023 | Noyes Timothy P81 | Chief Executive Officer | Sale+OE | 15,000 | $23.81 | $357,196.30 | -100% | -29.5% | +2.7% | |
| Feb 6, 2023 | Niven Ralph74 | Chief Scientific Officer | Sale+OE | 2,250 | $24.27 | $54,612.00 | -58.3% | -12.2% | -20.1% | |
| Feb 6, 2023 | Dake Benjamin T77 | See Remarks | Sale+OE | 10,284 | $24.59 | $252,881.25 | -100% | -12.2% | -20.1% | |
| Feb 1, 2023 | Noyes Timothy P81 | Chief Executive Officer | Sale+OE | 15,000 | $22.68 | $340,196.91 | -100% | -9.9% | -18.9% | |
| Jan 6, 2023 | Dake Benjamin T77 | See Remarks | Sale+OE | 10,284 | $25.98 | $267,202.68 | -100% | -28.7% | -23.5% | |
| Jan 5, 2023 | Niven Ralph74 | Chief Scientific Officer | Sale+OE | 2,250 | $26.40 | $59,404.50 | -58.3% | -31.0% | -27.0% | |
| Jan 3, 2023 | Noyes Timothy P81 | Chief Executive Officer | Sale+OE | 15,000 | $27.07 | $406,076.08 | -100% | -27.9% | -24.1% |